YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

JHPCY
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

seekingalpha.comPOSITIVO

Notable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus

Wall Street closed in the green on Friday after the September nonfarm payrolls report came in cooler than economists expected. The blue-chip Dow ended up 0.5%, the benchmark S&P 500 gained 0.7%, and the tech-focused Nasdaq Composite advanc…

seekingalpha.comPOSITIVO

Novo Nordisk strikes $2.6B obesity drug deal with China's Hengrui

[Novo Nordisk sign on building, Danish pharmaceutical healthcare giant, production innovative drugs, obesity treatment Ozempic, pharmaceutical company innovation, Mainz, Germany June 15, 2024] Victor Golmer Jiangsu Hengrui Pharmaceuticals…

seekingalpha.comPOSITIVO

Heart drug developer Braveheart Bio surges on public debut after upsized IPO

[IPO Initial Public Offering on Financial Stock Market Chart 3D render] gonin Braveheart Bio (BRVE [https://seekingalpha.com/symbol/BRVE]), a clinical-stage drug developer focused on cardiovascular diseases, made a strong public debut on T…

seekingalpha.comNEUTRAL

Kailera falls after late-stage trial data for oral GLP-1 candidate

[Red dollar sign pointing down with arrow, concept of financial loss, market decline and recession, 3d render] Shares of Kailera Therapeutics (KLRA [https://seekingalpha.com/symbol/KLRA]) slipped more than 10% on Tuesday after the Waltham,…

seekingalpha.comNEGATIVO

GLP-1 developer Kailera, proteomics firm Alamar file for U.S. IPOs

[IPO Ahead Financial Growth] narvo vexar Weight loss drug developer Kailera Therapeutics (KLRA [https://seekingalpha.com/symbol/KLRA]) and Alamar Biosciences (ALMR [https://seekingalpha.com/symbol/ALMR]), a commercial-stage proteomics comp…

seekingalpha.comNEGATIVO

Hengrui, Kailera phase 2 obesity pill results could pressure Eli Lilly's orforglipron

[Weight Loss Pill] Positive phase 2 results from Jiangsu Hengrui Pharmaceuticals (JNGHF [https://seekingalpha.com/symbol/JNGHF])(JHPCY [https://seekingalpha.com/symbol/JHPCY]) and privately held Kailera Therapeutics for their daily oral GL…